CMPX

Compass Therapeutics Inc.

Price

$2.39

return (12m)

-29.23%

p/e

-6.29

p/bv

2.78

DIVIDEND YIELD

0.00%

CMPX price

Compass Therapeutics Inc.

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CMPX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

23.26%

3 months

16.91%

1 year

-29.23%

2 years

57.95%

5 years

-31.86%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CMPX

Valuation

P/E

-6.29

Sector 7.79

Industry 7.79

P/BV

2.78

Sector 1.89

Industry 1.89

P/Revenue (PSR)

Sector 1.87

Industry 1.87

EV/EBITDA

Sector -807.06

Industry -807.06

EV/EBIT

Sector -111,566,543.17

Industry -111,566,543.17

P/EBITDA

Sector -81.30

Industry -81.30

P/EBIT

Sector -101.50

Industry -101.50

P/Total Assets

2.43

Sector 0.89

Industry 0.89

P/Net Current Assets

2.95

Sector -2.33

Industry -2.33

P/Working Capital

2.80

Sector -4,917.72

Industry -4,917.72

EPS

-0.39

Sector 0.72

Industry 0.72

BVPS

0.89

Sector 9.72

Industry 9.72

Efficiency

Gross Margin

0.00%

Sector 34.49%

Industry 34.49%

EBITDA Margin

Sector 1.84%

Industry 1.84%

EBIT Margin

Sector 0.24%

Industry 0.24%

Operating Margin

0.00%

Sector 4.22%

Industry 4.22%

Net Profit Margins

0.00%

Sector 2.53%

Industry 2.53%

Asset Turnover

0.00

Sector 0.11

Industry 0.11

Profitability

ROE

-44.23%

Sector 1.50%

Industry 1.50%

ROA

-38.62%

Sector -0.73%

Industry -0.73%

ROIC

0.00%

Sector -65.83%

Industry -65.83%

Dividends

Dividend yield

0.00%

Sector 0.50%

Industry 0.50%

Payout

Sector 10.25%

Industry 10.25%

Debt

Current Ratio

11.21

Sector 1.44

Industry 1.44

Net Debt / EBITDA

Sector -110,291,659.03

Industry -110,291,659.03

Net Debt / EBIT

Sector -466,032,166.33

Industry -466,032,166.33

Net Debt / Equity

0.00

Sector -0.80

Industry -0.80

Gross Debt / Equity

0.00

Sector -0.53

Industry -0.53

Equity/Assets

0.87

Sector 0.42

Industry 0.42

Liabilities/Assets

0.13

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-2.22%

Sector -

Industry -

Fundamentals CMPX

DRAG THE FRAME TO SEE MORE DATA

CMPX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Compass Therapeutics Inc.

Compass Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Compass Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $461.89 million, with shareholders equity totaling $166.05 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Compass Therapeutics Inc. reported $- in revenue, generating net income of $-73.45 million.

Key financial metrics include a P/E ratio of -6.29, a price-to-book (P/B) ratio of 2.78, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CMPX.

Market cap

$461.89 million

Net worth

$166.05 million

$166,050,000.00

Assets

$190.17 million

$190,170,000.00

Total Shares Outstanding

187.00 million

187,000,000

Average Daily Trading Volume

$3.05 million

$3,048,678.60

Sector

Others

Industry

Others

CMPX

CMPX revenue and profits

Financial Results CMPX

DRAG THE FRAME TO SEE MORE DATA

CMPX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$403.72 35,42% (12M)

P/E

23.73

2.28%

ROE

14.27%

P/BV

3.39

SHEL - Shell PLC ADR

$92.89 33,77% (12M)

P/E

9.78

3.25%

ROE

14.29%

P/BV

1.40

STLA - Stellantis NV

$5.47 --40,21% (12M)

P/E

-0.61

0.00%

ROE

-35.93%

P/BV

0.22

COR - Cencora Inc.

$336.74 14,96% (12M)

P/E

23.52

0.92%

ROE

81.48%

P/BV

19.17

ALIZY - Allianz SE ADR

$52.72 --6,02% (12M)

P/E

14.26

2.63%

ROE

17.89%

P/BV

2.55

TTE - TotalEnergies SE ADR

$90.15 58,11% (12M)

P/E

6.95

4.68%

ROE

21.42%

P/BV

1.49

NSRGY - Nestle SA ADR

$96.44 8,02% (12M)

P/E

11.66

4.13%

ROE

58.05%

P/BV

6.77

ELV - Elevance Health Inc

$414.53 32,18% (12M)

P/E

19.53

1.73%

ROE

9.84%

P/BV

1.92